AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34051293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32571311 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint frailty model
Number of subjects: 0
Study 32571311 — intervention group
Group type: COMPARATOR
Intervention: Negative binomial and shared frailty models
Number of subjects: 0
Study 35690952 — intervention group
Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 163
Study 35690952 — intervention group
Group type: EXPERIMENTAL
Intervention: ThuFLEP
Number of subjects: 163
Study 35690952 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 163
Study 34143385 — intervention group
Group type: EXPERIMENTAL
Intervention: Helichrysum microphyllum subsp. tyrrhenicum planted in mine waste materials
Number of subjects: 90
Study 34143385 — intervention group
Group type: EXPERIMENTAL
Intervention: Helichrysum microphyllum subsp. tyrrhenicum planted in mine wastes with compost
Number of subjects: 90
Study 34143385 — intervention group
Group type: EXPERIMENTAL
Intervention: Helichrysum microphyllum subsp. tyrrhenicum planted in reference substrate
Number of subjects: 90
Study 34515824 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD 25μg
Number of subjects: 83
Study 34515824 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD 50μg
Number of subjects: 83
Study 34515824 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD 100μg
Number of subjects: 83
Study 34515824 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD 200μg
Number of subjects: 83
Study 34515824 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (all doses combined)
Number of subjects: 83
Study 34909900 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 90
Study 34909900 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% tetracaine
Number of subjects: 90
Study 34909900 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 90
Study 34909900 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (NaCl)
Number of subjects: 90
Study 34310640 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led hospital-to-home transitional care intervention
Number of subjects: 127
Study 34310640 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 127
Study 32196845 — intervention group
Group type: EXPERIMENTAL
Intervention: Plateletcrit (PCT)
Number of subjects: 0
Study 36354034 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (8 mg) and Albendazole (400 mg)
Number of subjects: 536
Study 36354034 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin (200 μg/kg) and Albendazole (400 mg)
Number of subjects: 536
Study 33235299 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous tibial nerve stimulation (TASCI) intervention
Number of subjects: 640
Study 32414425 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 0
Study 32414425 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0
Study 32414425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32414425 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib monotherapy
Number of subjects: 0
Study 32414425 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate monotherapy or combination therapy
Number of subjects: 0
Study 32414425 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0
Study 32414425 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study 32414425 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily diaries during interruptions
Number of subjects: 0
Study 34595812 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 0
Study 34595812 — intervention group
Group type: COMPARATOR
Intervention: Humalog®
Number of subjects: 0
Study 33611923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 52
Study 33611923 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS (Control)
Number of subjects: 52
Study 35031340 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR (Stereotactic Ablative Radiotherapy)
Number of subjects: 62
Study 35031340 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 62
Study 36121246 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN) plus a phosphodiesterase‐5 inhibitor (PDE‐5i)
Number of subjects: 128
Study 36121246 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure plus a phosphodiesterase‐5 inhibitor (PDE‐5i)
Number of subjects: 128
Study 34322553 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-regulated volume control (PRVC)
Number of subjects: 30
Study 34322553 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV)
Number of subjects: 30
Study 34322553 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 30
Study 34322553 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 30
Study 32101034 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge drinking video describing sexual impotence
Number of subjects: 353
Study 32101034 — intervention group
Group type: COMPARATOR
Intervention: Cognitive or long-term deficits videos (not specified in detail)
Number of subjects: 353
Study 35045351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous trehalose (15 g once weekly) for 12 weeks
Number of subjects: 15
Study 35045351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 35045351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous trehalose
Number of subjects: 15
Study 33562341 — intervention group
Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice (240 mL once daily for 90 days)
Number of subjects: 27
Study 33562341 — intervention group
Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice (240 mL twice daily for 90 days)
Number of subjects: 27
Study 35184885 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth cutter (0.5 mm, Komet) (DC)
Number of subjects: 30
Study 35184885 — intervention group
Group type: EXPERIMENTAL
Intervention: Round bur (1.5 mm, Diatech) (RB)
Number of subjects: 30
Study 35184885 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibrated depth bur (laser mark of 0.5 mm, Gaofeng) (CD)
Number of subjects: 30
Study 33142847 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) > 30 min five days per week
Number of subjects: 12641
Study 33142847 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) > 30 min three to four days per week in high screen time (ST) group
Number of subjects: 12641
Study 33142847 — intervention group
Group type: EXPERIMENTAL
Intervention: First-time smokers under 10 years
Number of subjects: 12641
Study 33142847 — intervention group
Group type: EXPERIMENTAL
Intervention: High screen time (ST), low physical activity (PA), and smoking
Number of subjects: 12641
Study 33142847 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents from rural areas
Number of subjects: 12641
Study 34480793 — intervention group
Group type: EXPERIMENTAL
Intervention: Compulsory military service
Number of subjects: 4029
Study 34480793 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for back pain
Number of subjects: 4029
Study 34480793 — intervention group
Group type: EXPERIMENTAL
Intervention: First months of military service
Number of subjects: 4029
Study 34480793 — intervention group
Group type: EXPERIMENTAL
Intervention: General health care during military service
Number of subjects: 4029
Study 34480793 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and smoking prevention
Number of subjects: 4029
Study 32534724 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-hour time management workshop
Number of subjects: 80
Study 32534724 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 34106555 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetoscopic endoluminal tracheal occlusion (FETO)
Number of subjects: 196
Study 34106555 — intervention group
Group type: COMPARATOR
Intervention: Expectant care
Number of subjects: 196
Study 32233268 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of care questionnaire
Number of subjects: 107
Study 32233268 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical remission
Number of subjects: 107
Study 33903080 — intervention group
Group type: EXPERIMENTAL
Intervention: DM Expected Care Plan (ECP) Analyzer
Number of subjects: 115
Study 32308189 — intervention group
Group type: EXPERIMENTAL
Intervention: OH (starter feed containing 10% DM basis oat hay)
Number of subjects: 40
Study 32308189 — intervention group
Group type: EXPERIMENTAL
Intervention: OH‐FC (starter feed containing 10% DM basis oat hay and oat hay fed as free‐choice provision in different buckets)
Number of subjects: 40
Study 32308189 — intervention group
Group type: EXPERIMENTAL
Intervention: FC (starter feed and oat hay fed as free‐choice provision in different buckets)
Number of subjects: 40
Study 32308189 — intervention group
Group type: COMPARATOR
Intervention: CON (control, starter without oat hay)
Number of subjects: 40
Study 36254421 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional septoplasty
Number of subjects: 70
Study 36254421 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic septoplasty using Freer's incision
Number of subjects: 70
Study 36254421 — intervention group
Group type: COMPARATOR
Intervention: Comparison of post-operative mean SNOT-10 score between conventional and endoscopic techniques
Number of subjects: 70
Study 35499912 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 (fish oil; 1440 mg/day of docosahexaenoic acid)
Number of subjects: 60
Study 35499912 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 60
Study 34596090 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention for neonatal staff
Number of subjects: 166
Study 33865366 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based online platform for surgical education
Number of subjects: 0
Study 33865366 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical textbooks
Number of subjects: 0
Study 32472096 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning classifier for histopathological images
Number of subjects: 388
Study 32472096 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning classifier
Number of subjects: 388
Study 36136596 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR) - 5 hours time in bed for nine nights
Number of subjects: 10
Study 36136596 — intervention group
Group type: COMPARATOR
Intervention: Normal Sleep (NS) - ≥7 hours time in bed
Number of subjects: 10
Study 33198488 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift
Number of subjects: 226
Study 35291404 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol (ketamine + propofol)
Number of subjects: 150
Study 35291404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 150
Study 35291404 — intervention group
Group type: EXPERIMENTAL
Intervention: Isofol (isoflurane + propofol)
Number of subjects: 150
Study 32915864 — intervention group
Group type: EXPERIMENTAL
Intervention: Social networking
Number of subjects: 812
Study 32915864 — intervention group
Group type: EXPERIMENTAL
Intervention: Online gaming
Number of subjects: 812
Study 32915864 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall online activities
Number of subjects: 812
Study 32915864 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of PIU
Number of subjects: 812
Study 35474254 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT) with oral micronized 17β-estradiol 1 mg/day for hysterectomized women and 4% vaginal micronized progesterone gel 45 mg/day for 10 days each month added to estradiol for women with a uterus.
Number of subjects: 643
Study 35474254 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 643
Study 35474254 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher mean on-trial E2 levels
Number of subjects: 643
Study 35474254 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMT progression rate (μm/year)
Number of subjects: 643
Study 35474254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 643
Study 33663779 — intervention group
Group type: EXPERIMENTAL
Intervention: TriGuard 3 (TG3)
Number of subjects: 220
Study 33663779 — intervention group
Group type: COMPARATOR
Intervention: Control (no TG3)
Number of subjects: 220
Study 32354466 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction cards
Number of subjects: 100
Study 32354466 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaleidoscope
Number of subjects: 100
Study 32354466 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 33574033 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised regimen
Number of subjects: 53
Study 33574033 — intervention group
Group type: COMPARATOR
Intervention: Fixed regimen
Number of subjects: 53
Study 34610519 — intervention group
Group type: EXPERIMENTAL
Intervention: Maladaptive cognitive emotion regulation strategies (men)
Number of subjects: 168
Study 34610519 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive cognitive emotion regulation strategies (women)
Number of subjects: 168
Study 34610519 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive cognitive emotion regulation strategies (men)
Number of subjects: 168
Study 36109707 — intervention group
Group type: EXPERIMENTAL
Intervention: ReduRisk-program (n=357), comprising risk-adjusted delirium management, structured mobility training, and digitally supported planning of post-inpatient care, including polypharmacy management.
Number of subjects: 612
Study 36109707 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 612
Study 36109707 — intervention group
Group type: EXPERIMENTAL
Intervention: ReduRisk-program (n=357).
Number of subjects: 612
Study 34639604 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous online class group (SOCG)
Number of subjects: 54
Study 34639604 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous online class group (AOCG)
Number of subjects: 54
Study 32868544 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g TXA bolus/1g TXA infusion (Bolus Maintenance [BM])
Number of subjects: 966
Study 32868544 — intervention group
Group type: EXPERIMENTAL
Intervention: 2g TXA bolus/placebo infusion (Bolus Only [BO])
Number of subjects: 966
Study 32868544 — intervention group
Group type: COMPARATOR
Intervention: Placebo bolus/placebo infusion (Placebo)
Number of subjects: 966
Study 32868544 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g TXA bolus/1g TXA infusion (Bolus Maintenance [BM]) and 2g TXA bolus/placebo infusion (Bolus Only)
Number of subjects: 966
Study 35647824 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% hyaluronic acid gel Gengigel®
Number of subjects: 30
Study 35647824 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% hyaluronic acid spray Gengigel®
Number of subjects: 30
Study 35647824 — intervention group
Group type: COMPARATOR
Intervention: Control group (without HA)
Number of subjects: 30
Study 34034792 — intervention group
Group type: EXPERIMENTAL
Intervention: AVATAR-brief (6 sessions) plus TAU
Number of subjects: 345
Study 34034792 — intervention group
Group type: EXPERIMENTAL
Intervention: AVATAR-extended (12 sessions) plus TAU
Number of subjects: 345
Study 34034792 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 345
Study 33530745 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (20,000 units) injected subcutaneously the day before, day of, and day after surgery for 3 doses
Number of subjects: 56
Study 33530745 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 56
Study 33530745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 33530745 — intervention group
Group type: COMPARATOR
Intervention: Erythropoietin and Placebo
Number of subjects: 56
Study 32489005 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation intervention using a weight tracking app and daily/weekly questionnaires
Number of subjects: 100
Study 32489005 — intervention group
Group type: COMPARATOR
Intervention: Control group (daily self-weighing without intervention)
Number of subjects: 100
Study 32489005 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation intervention
Number of subjects: 100
Study 36192751 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin plus placebo (CP)
Number of subjects: 88
Study 36192751 — intervention group
Group type: COMPARATOR
Intervention: Coenzyme Q10 plus placebo (QP)
Number of subjects: 88
Study 36192751 — intervention group
Group type: COMPARATOR
Intervention: Curcumin plus coenzyme Q10 (CQ)
Number of subjects: 88
Study 36192751 — intervention group
Group type: COMPARATOR
Intervention: Double placebo (DP)
Number of subjects: 88
Study 33118138 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application intervention (n=34)
Number of subjects: 68
Study 33118138 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (n=34)
Number of subjects: 68
Study 34526337 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative care for enhanced recovery
Number of subjects: 260
Study 34526337 — intervention group
Group type: COMPARATOR
Intervention: Conventional perioperative care
Number of subjects: 260
Study 34526337 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery protocol
Number of subjects: 260
Study 35715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting xerostomia
Number of subjects: 365
Study 35715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Tree Classifier (DTC) model for predicting xerostomia
Number of subjects: 365
Study 35715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme-Gradient Boosting (XGB) model for predicting xerostomia
Number of subjects: 365
Study 35715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting Grade 3 xerostomia
Number of subjects: 365
Study 33469794 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ERAS implementation
Number of subjects: 168
Study 33469794 — intervention group
Group type: COMPARATOR
Intervention: Pre-ERAS implementation
Number of subjects: 168
Study 35081856 — intervention group
Group type: EXPERIMENTAL
Intervention: Streaming music with a special binaural beat frequency (MBB)
Number of subjects: 267
Study 35081856 — intervention group
Group type: COMPARATOR
Intervention: Streaming simple music (SM)
Number of subjects: 267
Study 35081856 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267
Study 34281600 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxiao Jiuxin Pill (SJP)
Number of subjects: 324
Study 34281600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study 33534904 — intervention group
Group type: EXPERIMENTAL
Intervention: Poisson binomial method
Number of subjects: 0
Study 33534904 — intervention group
Group type: COMPARATOR
Intervention: Midpoint and random-point methods
Number of subjects: 0
Study 33230185 — intervention group
Group type: EXPERIMENTAL
Intervention: Periocular skin warming
Number of subjects: 18
Study 33230185 — intervention group
Group type: COMPARATOR
Intervention: Sham eye mask
Number of subjects: 18
Study 33993893 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 4950
Study 33993893 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell (RBC) transfusion
Number of subjects: 4950
Study 33993893 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusions of >3 units
Number of subjects: 4950
Study 33993893 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusions of 0-3 units
Number of subjects: 4950
Study 35623048 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day antibiotic therapy
Number of subjects: 66
Study 35623048 — intervention group
Group type: COMPARATOR
Intervention: 20-day antibiotic therapy
Number of subjects: 66
Study 34098395 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen (2 g fibrinogen concentrate diluted in 100 ml distilled water, intravenously 15-30 min before surgery)
Number of subjects: 70
Study 34098395 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 ml normal saline, intravenously 15-30 min before surgery)
Number of subjects: 70
Study 32277749 — intervention group
Group type: EXPERIMENTAL
Intervention: Gospel music program with weekly, 45-minute vocal and instrumental sessions
Number of subjects: 0
Study 32277749 — intervention group
Group type: EXPERIMENTAL
Intervention: Gospel music program
Number of subjects: 0
Study 32277749 — intervention group
Group type: COMPARATOR
Intervention: Cardiovascular lifestyle education sessions alone (Control)
Number of subjects: 0
Study 32277749 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 35488866 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH+ intervention consisting of behavior, cognitive, and motivation components, food monitoring, and a skill consolidation phase delivered via outpatient telehealth sessions for 6 months
Number of subjects: 60
Study 35488866 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study 35654820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methotrexate (MTX) and 6-mercaptopurine (6-MP) as maintenance therapy
Number of subjects: 0
Study 35654820 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopurine Enhanced ALL Maintenance (TEAM) strategy
Number of subjects: 0
Study 35654820 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticosteroid/vincristine pulses
Number of subjects: 0
Study 35654820 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 0
Study 34001277 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Living with Challenge (MLWC) intervention
Number of subjects: 1600
Study 34001277 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 1600
Study 32965249 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg per day with titration of 100 mg once a month + synbiotic 1 capsule three times a day
Number of subjects: 68
Study 32965249 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol monotherapy
Number of subjects: 68